Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension
Prof Roberto Fogari, Stefano Taddei, Merete Holm-Bentzen, Jacek Baszak, Lorenzo Melani, Kai SchumacherVolume:
30
Language:
english
DOI:
10.2165/11536710-000000000-00000
Date:
September, 2010
File:
PDF, 189 KB
english, 2010